logo Fabry logo

  • 1

Biomarkers, Progression and Treatment Opportunities 

April 25-27, 2017 - Mexico City, Mexico

An Official Satellite of the ISN WORLD CONGRESS OF NEPHROLOGY 2017

Supporting Organization: Kidneys for Life

Secretariat: CONGREX.COM.PA

Meeting Co-Chairs

  • Ricardo Correa-Rotter, Inst. Nacional de Ciencias Médicas y Nutrición Salvador Zubirán and National Autonomous University of México, Mexico City
  • Derralyn Hughes, Royal Free London NHS Foundation Trust University College London, London, UK
  • Luiz Antonio Ribeiro Moura, Escola Paulista de Medicina - Federal University of Sao Paulo, Brazil
  • Gregorio T. Obrador Vera, Universidad Panamericana School of Medicine, Mexico City, Mexico
  • Juan M. Politei, Fundación Para El Estudio De Las Enfermedades Neurometabólicas, Buenos Aires, Argentina
  • Raphael Schiffmann, Baylor Research Institute, Dallas, Texas USA
  • Hernán Trimarchi, Hospital Britanico de Buenos Aires, Buenos Aires, Argentina
  • Stephen Waldek, School of Pharmacy, University of Sunderland, Sunderland UK
  • Christoph Wanner, University of Würzburg, Würzburg Germany
  • David G. Warnock, University of Alabama at Birmingham, Birmingham, AL USA
  • Michael West, QE II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada

The 1st Fabry Nephropathy Satellite “Focus on Fabry Nephropathy: Biomarkers, Progression and Disease Severity”, an Official Satellite of the World Congress of Nephrology, was held in Bergamo Italy in May 2009. The second Fabry Nephropathy Satellite “Focus on Fabry Nephropathy: Biomarkers, Progression and Treatment Opportunities” was organized as an Official Satellite of the World Congress of Nephrology, and was held in Vancouver, Canada on April 12–14, 2011. The 3rd Update on Fabry Nephropathy was held in conjunction with the World Congress of Nephrology, in Hong Kong on June 4-5, 2013.  The 4th Fabry Nephropathy Update was a Satellite of the ERA_EDTA 2015 Meeting, and was held in Manchester, UK on June 1-2, 2015. The 5th Fabry Nephropathy Update is an official  Satellite of the 2017 ISN WCN Meeting, and will be held in Mexico City, Mexico on April 25-27, 2017. The 2 day conference features, key note addresses, state of the art plenary presentations, structured debates and poster presentations. The intended audience are content experts and "treaters" of Fabry Disease. The focus will be on emerging treatment approaches, and baseline characteristics that determine the patient-specific responses to the treatment of Fabry disease.

  wcnfabry